Search for stocks /

KK Shah Hospitals Ltd H1 FY26 – ₹4.82 Cr Revenue, ₹0.47 EPS Loss, 28% Bed Occupancy & a Healthcare Startup Learning to Walk While Running


1. At a Glance – Emergency Ward Summary (Because This One Needs It)

KK Shah Hospitals Ltd is a ₹25.5 crore market cap SME-listed healthcare company trading around ₹37.5 per share, and if price action were a medical symptom, it would be classified as mild dizziness with chronic fatigue. The stock is down ~12.8% over three months, six-month returns are negative, and profitability is still in the ICU. Latest half-year numbers show ₹4.82 crore revenue, PAT loss of ₹0.32 crore, and EPS of -₹0.47 for H1 FY26.

The hospital is operational, expanding, adding CT scans, robotic surgery toys, and even opening a new hospital at Thandla, but the financial vitals show a classic early-stage healthcare problem: revenues growing, costs growing faster, depreciation hitting like a hammer, and margins doing yoga in reverse. ROCE stands at -2.33%, ROE at -2.40%, and EV/EBITDA at a spicy 28.8x, which is bold for a company still figuring out how to fill beds consistently.

Promoters hold a strong 71.36%, debt is zero, current ratio is 2.66, and the balance sheet looks clean. The income statement, however, looks like a medical intern wrote it on their first night shift. Curious already? You should be.


2. Introduction – A Hospital Born via Acquisition, Baptised by Losses

KK Shah Hospitals Ltd didn’t grow organically from a single stethoscope and a dream. It was born via a Business Transfer Agreement, acquiring the legacy Shah Hospital (formerly Shah Maternity and Nursing Home and Jeevan Parv Healthcare Limited) on 31 December 2022. In classic Indian SME fashion, the hospital business was restructured, rebranded, relisted, and relaunched with fresh equity and even fresher optimism.

By November 2023, the company raised ₹8.775 crore through its IPO, issued 19.5 lakh shares, and listed on the BSE SME platform. The pitch was simple: Ratlam needs organised healthcare, the hospital already exists, and with capital infusion, expansion and technology upgrades would follow.

And follow they did. CT Scan machine? Installed. New hospital at Thandla? Commenced. Robotic knee surgery system? Why not. Peripheral OPDs? Announced. On paper, KK Shah Hospitals behaves like a hospital on growth steroids.

But markets don’t clap for MRI machines alone. They want occupancy, margins, and return ratios. And here’s where the story gets more… clinical.


3. Business Model – WTF Do They Even Do? (Explained Like You’re Waiting Outside OT)

KK Shah Hospitals Ltd runs a multi-speciality hospital model focused on Tier-III / semi-urban healthcare demand. The services span:

General Surgery, Orthopaedics, Obstetrics & Gynaecology, Internal Medicine, Gastrointestinal Surgery, Urology, ENT, Anaesthesiology, Dental, Emergency Care, and Physiotherapy.

Translation: Everything except cosmetic influencer Botox.

Revenue primarily comes from sale of healthcare services (93%), with a small 7% from interest income. This is a classic IPD + OPD hospital model where profitability depends on:

  • Bed occupancy
  • Surgery volumes
  • Average Revenue Per Occupied Bed (ARPOB)
  • Diagnostic utilisation

In FY22, the hospital conducted 75–80 surgeries per month. By FY23, patient handling scaled to 2,200–2,350 patients per month, with 200–250 indoor patients and the rest OPD. Sounds busy, right? Now comes the plot twist.

Despite patient volumes, bed occupancy was only ~28% in December 2022, with an average IPD of 7.19 patients per day. That’s like owning a 100-seater bus and carrying 28 people while still paying EMI on the full bus.

The hospital is NABH accredited (primary-level), employs 39 staff, works with 12 associated doctors and 9 visiting consultants, and is operationally real. The business exists.

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!